
TransCode Therapeutics, Inc. (RNAZ) CEO Michael Dudley on Q4 2021 Results – Earnings Call Transcript
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Q4 2021 Earnings Conference Call April 7, 2022 4:30 PM ET Company Participants Alan Freidman – Vice President, Investor Relations Michael Dudley – Co-Founder, Chief Executive Officer, and Director Thomas Fitzgerald […]